long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 16:57 (83 d 16:58 ago) – Posting: # 21798
Views: 1,568

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

Activity
 Admin contact
21,170 posts in 4,411 threads, 1,475 registered users;
online 6 (1 registered, 5 guests [including 2 identified bots]).
Forum time: Wednesday 09:55 CEST (Europe/Vienna)

But it is in matters beyond the limits of mere rule
that the skill of the analyst is evinced.
He makes in silence a host of observations and inferences…    Edgar Allan Poe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5